Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 025418/0617 | |
| Pages: | 3 |
| | Recorded: | 11/24/2010 | | |
| Attorney Dkt #: | SMAR:002US/10900563 |
| Conveyance: | CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
2
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12374277
|
Filing Dt:
|
12/10/2009
|
|
Publication #:
|
|
Pub Dt:
|
04/08/2010
| | | | |
|
Title:
|
DISPARATE SUICIDE CARRIER CELLS FOR TUMOR TARGETING OF PROMISCUOUS ONCOLYTIC VIRUSES
|
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
12375361
|
Filing Dt:
|
10/14/2009
|
|
Publication #:
|
|
Pub Dt:
|
02/24/2011
| | | | |
|
Title:
|
STAGED IMMUNE-RESPONSE MODULATION IN ONCOLYTIC THERAPY
|
|
|
Assignee
|
|
|
|
|
| 725 PARKDALE AVENUE |
| OTTAWA, ONTARIO, CANADA K1Y 4E9 |
|
|
Correspondence name and address
|
| |
CASEY BLESSING C/O CHARLES P. LANDRUM
|
| |
600 CONGRESS AVE.
|
| |
SUITE 2400
|
| |
AUSTIN, TX 78701
|
Search Results as of:
06/25/2024 09:50 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
| 
